These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10908009)

  • 1. The CSAT methamphetamine treatment project: what are we trying to accomplish?
    Anglin MD; Rawson RA
    J Psychoactive Drugs; 2000; 32(2):209-10. PubMed ID: 10908009
    [No Abstract]   [Full Text] [Related]  

  • 2. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM; Taylor JA; Gallagher C; Dawud-Noursi S
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine abuse: issues for special populations.
    Freese TE; Obert J; Dickow A; Cohen J; Lord RH
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A; Lord RH; Gulati V; Marinelli-Casey P; Rawson R; Ling W
    J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
    Reiber C; Galloway G; Cohen J; Hsu JC; Lord RH
    J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-as-usual in the methamphetamine treatment project.
    Galloway GP; Marinelli-Casey P; Stalcup J; Lord R; Christian D; Cohen J; Reiber C; Vandersloot D
    J Psychoactive Drugs; 2000; 32(2):165-75. PubMed ID: 10908004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
    J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving research into community settings in the CSAT methamphetamine treatment project: the coordinating center perspective.
    Rawson RA; McCann MJ; Huber A; Marinelli-Casey P; Williams L
    J Psychoactive Drugs; 2000; 32(2):201-8. PubMed ID: 10908008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conducting trials in community settings: the provider perspective.
    Zweben JE; Cohen JB; Obert J; Vandersloot D; Marinelli-Casey P
    J Psychoactive Drugs; 2000; 32(2):193-9. PubMed ID: 10908007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL; McCann MJ; Marinelli-Casey P; Weiner A; Minsky S; Brethen P; Rawson R
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr; 64(73):18922-3. PubMed ID: 10558551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiscal year (FY) 1998 funding opportunities--SAMHSA. Notice of funding availability.
    Fed Regist; 1998 Apr; 63(77):19928-32. PubMed ID: 10179317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine: an epidemic of oral health neglect, loss of access to care, abuse, and violence.
    Assael LA
    J Oral Maxillofac Surg; 2005 Sep; 63(9):1253-4. PubMed ID: 16122586
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the 20% D-methamphetamine requirement for determining illicit use of methamphetamine in urine.
    Esposito FM; Crumpton S; Mitchell J; Flegel RR
    J Anal Toxicol; 2012 Jul; 36(6):399-404. PubMed ID: 22586207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking research and service delivery: the unique mission of the Substance Abuse and Mental Health Services Administration.
    Jansen MA
    NIDA Res Monogr; 1994; 140():23-6. PubMed ID: 8722449
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalant abuse treatment and prevention.
    Public Health Rep; 2003; 118(3):276. PubMed ID: 12820632
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP; Simon SL; Rawson RA; Huber A; Ling W
    J Psychoactive Drugs; 2000; 32(2):229-32. PubMed ID: 10908012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating drug abuse treatment: a comment on the state of the art.
    Jaffe JH
    NIDA Res Monogr; 1984; 51():13-28. PubMed ID: 6095081
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating substance abuse treatment need by state.
    Gfroerer J; Epstein J; Wright D
    Addiction; 2004 Aug; 99(8):938-9. PubMed ID: 15265089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.